VAERS Reports U7295AA

VAERS 2618090

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

schwer

Staat: MN
Alter: -
Geschlecht: M
Eingang: 27.09.2023
Impfdatum: 14.04.2023
Beginn: 17.04.2023
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood lactic acid Brain natriuretic peptide normal Full blood count abnormal Mean cell volume decreased Metabolic function test normal Mean cell volume normal Platelet count increased Seizure like phenomena Sudden onset of sleep Tremor

Symptomtext

Seizure like activity-full body shaking upon feeding afternoon bottle (had eaten 1/2 the bottle, or 1.5-2 oz.); Seizure like activity-full body shaking upon feeding afternoon bottle (had eaten 1/2 the bottle, or 1.5-2 oz.); Seizure like activity-full body shaking upon feeding afternoon bottle (had eaten 1/2 the bottle, or 1.5-2 oz.); Seizure like activity-full body shaking upon feeding afternoon bottle (had eaten 1/2 the bottle, or 1.5-2 oz.); Seizure like activity-full body shaking upon feeding afternoon bottle (had eaten 1/2 the bottle, or 1.5-2 oz.); Seizure like activity-full body shaking upon feeding afternoon bottle (had eaten 1/2 the bottle, or 1.5-2 oz.); This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2618090-1. The original narrative from the sender is as follows: On 17-Apr-2023, after vaccination with Vaxelis on 14-Apr-2023, a four-month-old neonate experienced seizure like activity-full body shaking upon feeding afternoon bottle (had eaten half of the bottle, or (about 1.5-2 ounces). Afterward the neonate fell asleep for about twenty minutes. The neonate was reported to be in normal state of health upon waking up. He was brought in and had an evaluation in the ER (emergency room) about one hour after the event. At that time, he had a normal physical exam. Lab results were reported as CBC (complete blood count): wnl (within normal limits), Plt (Platelets): 550, MCV (mean corpuscle volume): 50, BMP (basic metabolic panel): wnl (within normal limits), and lactic acid: 2.2. Due to the nature of the event the causal relationship between Vaxelis and the event, "Seizure like activity-full body shaking upon feeding afternoon bottle (had eaten 1/2 the bottle, or 1.5-2 oz.)" was assessed as related, whereas, the events, "blood lactic acid", "brain natriuretic peptide normal", "full blood count abnormal", "mean cell volume normal", "platelet count increased" were considered not applicable. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2655914

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

mild

Staat: PA
Alter: -
Geschlecht: M
Eingang: 28.12.2023
Impfdatum: 13.07.2023
Beginn: 13.07.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Diet refusal Erythema Infant irritability Injection site urticaria Poor feeding infant Skin warm Urticaria

Symptomtext

Patient refused to nurse following vaccine administration; Hives began to appear a few minutes after vaccines were given to bilateral legs as well as the patient's back.; Patient was very warm to the touch and red.; Patient was very warm to the touch and red.; Very irritable; Poor feeding infant; Hives began to appear a few minutes after vaccines were given to bilateral legs as well as the patient's back.; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2655914-1. The original narrative from the sender is the following: "Patient refused to nurse following vaccine administration. Hives began to appear a few minutes after vaccines were given to bilateral legs as well as the patient's back. Patient was very warm to the touch and red. Very irritable. 9mg of Benadryl were given when this occurred. Patient began to improve around 15 min later". The reporter assessed the casual relationship between Vaxelis and the events " Patient refused to nurse following vaccine administration"," Patient refused to nurse following vaccine administration"," Patient was very warm to the touch and red.", "Very irritable ", " Poor feeding infant" and" Hives began to appear a few minutes after vaccines were given to bilateral legs as well as the patient's back" as related. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Respiratory distress (Patient was in NICU at birth or respiratory distress. 4 day stay.)
Andere Medikamente: VITAMIN D 3
Allergien: -
Vorherige Impfungen: -

VAERS 2675856

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

mild

Staat: UT
Alter: -
Geschlecht: F
Eingang: 27.12.2023
Impfdatum: 21.08.2023
Beginn: 23.08.2023
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash

Symptomtext

a rash errupted all over patients skin; This spontaneous safety report, with reference number 2675856 (VAERS ID # 2675856-1) was received by the partner on 22-SEP-2023 and forwarded to Agency on 26-SEP-2023, from a health professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "a rash errupted all over patients skin". No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2675856

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

mild

Staat: UT
Alter: -
Geschlecht: F
Eingang: 27.12.2023
Impfdatum: 21.08.2023
Beginn: 23.08.2023
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash

Symptomtext

a rash errupted all over patients skin; This spontaneous safety report, with reference number 2675856 (VAERS ID # 2675856-1) was received by the partner on 22-SEP-2023 and forwarded to Agency on 26-SEP-2023, from a health professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "a rash errupted all over patients skin". No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630747

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

mild

Staat: CO
Alter: -
Geschlecht: F
Eingang: 27.09.2023
Impfdatum: 25.04.2023
Beginn: 25.04.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site haematoma Injection site swelling Subcutaneous haematoma

Symptomtext

Initial redness and swelling at injection site, transitioned into 1.3cm subq hematoma; Initial redness and swelling at injection site; Initial redness and swelling at injection site; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2630747-1. The original narrative from the sender is the following: "Initial redness and swelling at injection site, transitioned into 1.3cm subq hematoma". The reporter did not provide the causal relationship between Vaxelis and the event, " Initial redness and swelling at injection site, transitioned into 1.3cm subq hematoma ". No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2658510

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: WY
Alter: -
Geschlecht: M
Eingang: 28.12.2023
Impfdatum: 19.07.2023
Beginn: 19.07.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Breath holding Crying Cyanosis Pallor

Symptomtext

patient went cyanotic; experienced a breath-holding spell; patient became pale; continued crying; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2658510-1. The original narrative from the sender is the following: "Gave patient Prevnar 13 vaccination in left thigh and then immediately gave Vaxelis in right thigh and patient went cyanotic and experienced a breath-holding spell and then shortly after took a breath, recovered and then continued crying, then 5-7 minutes later patient became pale. Continuous oxygen saturations were monitored and stayed above 97%. Patient's color returned to normal within 30 minutes after episode. After discussion with doctor, it has been decided that future vaccinations will be given individually at different times for this patient". The reporter assessed the causal relationship between Vaxelis and the events "patient went cyanotic ", "experienced a breath-holding spell ", "patient became pale" and " continued crying" as related. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Breath holding
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2727563

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: KS
Alter: 0,2
Geschlecht: M
Eingang: 27.12.2023
Impfdatum: 20.11.2023
Beginn: 20.12.2023
Tage bis Beginn: 30,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product administered to patient of inappropriate age

Symptomtext

Individual did not experience any adverse reactions. Influenza was given under recommended age.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2696114

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: AR
Alter: 0,2
Geschlecht: M
Eingang: 14.10.2023
Impfdatum: 11.10.2023
Beginn: 11.10.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood electrolytes normal Blood glucose normal Chest X-ray Crying Electrocardiogram Hypopnoea Hyporesponsive to stimuli Hypotonia Immediate post-injection reaction Pallor

Symptomtext

Patient cried immediately following injections but had no breath-holding spells. Mom consoled baby and began to place him in his car seat 5-7 minutes after vaccines given. Mom immediately noted that he was becoming very pale, limp, and poorly responsive (not apneic) and brought him out of the exam room to the Nurses' station calling for help. The nurses and I saw him at that time. He was (1) diffusely very pale, including his lips, (2) breathing shallowly, (3) eyes were open mostly, (4) very hypotonic, and (5) minimally responsive.. We took him back to the exam room. Heart rate was 60-80. No resuscitation needed. Color and tone slowly improved over a 30-minute period and he was transferred to a local pediatric ED for evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood electrolytes normal
Hospital-Tage: -
Labordaten: ECG and CXR , glucose and electrolytes were normal.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2692350

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: CO
Alter: 0,2
Geschlecht: F
Eingang: 06.10.2023
Impfdatum: 06.10.2023
Beginn: 06.10.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Swelling of eyelid

Symptomtext

Patient received Beyfortus (RSV mAb nirsevimab, 0.5mL) LOT: 2022829 in the Left thigh at 0900. Mother called post visit at 1600 and states she noticed eyelid swelling at 1500. No other symptoms reported. Mother was advised to have patient seen in urgent care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Swelling of eyelid
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2688176

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: HI
Alter: -
Geschlecht: U
Eingang: 28.09.2023
Impfdatum: 17.07.2023
Beginn: 17.07.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Device data issue

Symptomtext

A HCP called to report a data logger discrepancy in which he was not able to report what temperature doses of administered VAXELIS and VAXNUEVANCE were maintained at. No additional AE information was able to be provided; This non-serious spontaneous safety report, with reference number, was received by a partner on 18-JUL-2023 and forwarded to agency on 19-JUL-2023, from a HCP. The causal relationship between Vaxelis and the reported event "A HCP called to report a data logger discrepancy in which he was not able to report what temperature doses of administered VAXELIS and VAXNUEVANCE were maintained at. No additional AE information was able to be provided." was assessed as not applicable due to the nature of the event. Further information is expected. Significant Follow-up information was received by the partner on 31-JUL-2023 and forwarded to agency on 01-AUG-2023, from a HCP. The case is maintained as non-serious. The causal relationship between Vaxelis and the reported event "A HCP called to report a data logger discrepancy in which he was not able to report what temperature doses of administered VAXELIS and VAXNUEVANCE were maintained at. No additional AE information was able to be provided." was assessed as not applicable due to the nature of the event. Further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Device data issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2617600

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: NM
Alter: -
Geschlecht: F
Eingang: 28.09.2023
Impfdatum: 14.04.2023
Beginn: 14.04.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

I realized the Moderna 6 mo.-5 yr primary series vaccine expired on 04/13/2023; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-APR-2023 with the following VAERS Primary ID 2617600-1. The original narrative from the sender is as follows: The patient presented today (14-APR-2023) for routine six-month well childcare and vaccines/flu and covid vaccine as well. After the immunizations were administered and documentation was being completed, it was realized the Moderna 6 month-5 year primary series vaccine expired on 13-APR-2023. The patient and mother left the clinic when this error was discovered. Due to the nature of the event the causal relationship between Vaxelis and the events, "I realized the Moderna 6 mo.-5 yr primary series vaccine expired on 04/13/2023" is not applicable. No further information is not expected. MAH notes: Based on the available information, the event was not related to Vaxelis but to Covid-19 vaccine. Vaxelis should have been considered a concomitant, however the case was retrieved from VAERS and information was kept as reported in the form.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2687483

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 27.09.2023
Impfdatum: 06.07.2023
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Off label use

Symptomtext

Dr wants to find out if VAXELIS can be given to a 5 year old pt,Physician reported child was ordered by another practitioner in the office to receive VAXELIS as part of catchup schedule,Sending due to off-label use as part of catchup schedule; Dr wants to find out if VAXELIS can be given to a 5 year old pt,Physician reported child was ordered by another practitioner in the office to receive VAXELIS as part of catchup schedule,Sending due to off-label use as part of catchup schedule; This non-serious spontaneous safety report with reference number #2023SA238033 (Inquiry #01714708) was received by a partner on 02-AUG-2023 and forwarded on 04-AUG-2023 from a health care professional. This case was considered non-valid due to the lack of patient identifiers. Due to the nature of the events, the causality between the events "Dr wants to find out if VAXELIS can be given to a 5 year old pt, Physician reported child was ordered by another practitioner in the office to receive VAXELIS as part of catchup schedule, Sending due to off-label use as part of catchup schedule" and Vaxelis was not applicable. Further information is expected. Significant Follow-up information was received by the partner on 22-AUG-2023 and forwarded on the same day, from a physician. This case is maintained as non-serious. This case was considered off-label due to use in unapproved age group. Due to the nature of the events, the causality between the events "Dr wants to find out if VAXELIS can be given to a 5-year-old pt, Physician reported child was ordered by another practitioner in the office to receive VAXELIS as part of catchup schedule, Off label use in unapproved age group" and Vaxelis was not applicable. Further information is expected. Duplicate information was received by the partner on 25-AUG-2023 and forwarded on 25-AUG-2023, from a physician. This case is maintained as non-serious. This case was considered off-label due to use in unapproved age group. Due to the nature of the events, the causality between the events "Dr wants to find out if VAXELIS can be given to a 5-year-old pt, Physician reported child was ordered by another practitioner in the office to receive VAXELIS as part of catchup schedule, Off label use in unapproved age group" and Vaxelis was not applicable. Further information is not expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Off label use
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Acute myeloid leukemia
Vorgeschichte: Medical History/Concurrent Conditions: Bone marrow transplant
Andere Medikamente: HEXAXIM
Allergien: -
Vorherige Impfungen: -

VAERS 2687427

UNKNOWN MANUFACTURER · MEASLES + MUMPS + RUBELLA (NO BRAND NAME) · Charge U7295AA

gering

Staat: TX
Alter: -
Geschlecht: M
Eingang: 27.09.2023
Impfdatum: 07.07.2023
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

Patient was accidentally administered with VAXELIS today even though he did not need it; This spontaneous safety report, with reference number 2023SA208212 (Inquiry number 01683246), was received by a partner on 07-JUL-2023 and forwarded to company on 10-JUL-2023, from a HCP. The causal relationship between Vaxelis and the reported event "Patient was accidentally administered with VAXELIS today even though he did not need it" was assessed as not applicable due to the nature of the event. Further information is expected. Significant Follow-up information was received by the partner on 02-AUG-2023 and forwarded to company on the same day, from a physician. This case is maintained as non-serious. The causal relationship between VAXELIS and the reported event of "Patient was accidentally administered with VAXELIS today even though he did not need it" is not applicable." No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642353

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: CA
Alter: -
Geschlecht: M
Eingang: 27.09.2023
Impfdatum: 06.06.2023
Beginn: 06.06.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Wrong product administered

Symptomtext

Patient came to received pneumococcal vaccine and was given Vaxelis (DTaP+IPV+Hib+HepB) instead; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2642353-1. The original narrative from the sender is the following: "Patient came in the office to receive pneumococcal vaccine and was given Vaxelis (DTaP+IPV+Hib+HepB) instead. Once realized, parent and PCP were informed. Patient was then given the correct vaccine, PCV15". The causal relationship between Vaxelis and the event "Patient came to received pneumococcal vaccine and was given Vaxelis (DTaP+IPV+Hib+HepB) instead" was assessed as not applicable due to the nature of this reported event. No further information is expected

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2649651

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7295AA

gering

Staat: MN
Alter: -
Geschlecht: F
Eingang: 27.06.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination error

Symptomtext

Patient was given Vaxelis an ACTHIB on the same day; Patient was given Vaxelis an ACTHIB on the same day; This non-serious spontaneous safety report was received by partner on 10-MAY-2023 and forwarded to agency on 11-MAY-2023 from a consumer. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Patient was given Vaxelis an ACTHIB on the same day". Further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Prophylaxis
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -